Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOONSONG: AT-527 in mild or moderate COVID-19
NCT04709835Phase 2Completed
- Sponsor
- Roche
- Start
- Feb 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of bemnifosbuvir in coronavirus disease 2019 (COVID-19), sponsored by Roche. Started Feb 2021; status: completed.
02
Drugs
bemnifosbuvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04709835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04709835.